Effects Of Turkish Coffee Consumption On Cardiovascular Markers And Sleep In Healthy Women
TURCOFFEE
Short Term Turkish Coffee Consumption Elevates Cardiovascular Risk Markers, Decreases Leptin Hormone Levels, and Impairs Sleep Quality in Healthy Young Women: A Pilot Randomized Controlled Trial
2 other identifiers
interventional
40
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the short-term effects of daily unfiltered Turkish coffee consumption on cardiovascular parameters, appetite-regulating hormones, glucose metabolism, inflammatory markers, and sleep quality in healthy young women. Forty participants will be randomly assigned to an intervention group, consuming standardized servings of Turkish coffee for four weeks, or to a control group abstaining from coffee during the same period. Measurements will be taken at baseline and after the intervention, including blood pressure, lipid profile, leptin, ghrelin, glucose metabolism markers, inflammatory biomarkers, body composition, and sleep quality indices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 21, 2025
CompletedAugust 21, 2025
August 1, 2025
3 months
August 5, 2025
August 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in systolic and diastolic blood pressure after 4 weeks of Turkish coffee consumption
Systolic and diastolic blood pressure were measured at baseline and after 4 weeks using a validated electronic monitor (Omron M6). Participants were seated in a relaxed position, and the average of two readings was recorded. The change in blood pressure levels was used to assess cardiovascular effects of Turkish coffee consumption.
Baseline and Week 4
Secondary Outcomes (1)
Change in serum leptin and ghrelin levels after 4 week
Baseline and Week 4
Study Arms (2)
Intervention
EXPERIMENTALStandardized Turkish coffee (unfiltered and boiled) was administered once daily for 4 weeks. Each serving was approximately 75 mL, prepared using a consistent protocol without added sugar or milk. The coffee was sourced from the same batch and brewed in a traditional cezve. Compliance and adverse effects were monitored throughout the intervention.
control
NO INTERVENTIONParticipants assigned to the control group were instructed to avoid all forms of coffee for the duration of the 4-week intervention period. They did not receive any dietary or behavioral instructions beyond abstaining from coffee consumption.
Interventions
Standardized Turkish coffee (unfiltered and boiled) was administered once daily for 4 weeks. Each serving was approximately 75 mL, prepared using a consistent protocol without added sugar or milk. The coffee was sourced from the same batch and brewed in a traditional cezve. Compliance and adverse effects were monitored throughout the intervention.
Eligibility Criteria
You may qualify if:
- Healthy female participants aged between 18 and 35 years
- Body Mass Index (BMI) between 18.5 and 29.9 kg/m²
- Habitual coffee consumers (1-2 cups/day)
- Not on a weight-loss or special medical diet
- Not taking medications or supplements that affect sleep, appetite, metabolism, or cardiovascular function
- Non-smokers and not using recreational drugs
- Willing to comply with study protocol and attend all assessments
You may not qualify if:
- Pregnancy or lactation
- Diagnosed chronic diseases (e.g., diabetes, hypertension, cardiovascular disease)
- Known sleep disorders or psychological conditions
- Allergy or sensitivity to coffee or caffeine
- Irregular menstrual cycle or hormonal disorders
- Shift workers or frequent travelers across time zones
- Participation in other clinical trials within the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UOP
Amman, 961343, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No blinding was implemented. Both participants and researchers were aware of group assignment due to the nature of the intervention (coffee consumption).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Amman. Jordan
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 21, 2025
Study Start
August 1, 2024
Primary Completion
October 30, 2024
Study Completion
October 30, 2024
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
The individual participant data (IPD) will not be shared due to confidentiality concerns and ethical limitations related to the nature of the data collected. The data include sensitive health and behavioral variables that cannot be adequately de-identified.